Infa, Inc. is the official U.S. sales office for Labochim S.P.A. and Mediolast S.p.A., two Italian manufacturers with a long and successful history in the API and custom synthesis business. Infa acquired Mediolast in October 2007. Between the two companies we offer more than 90 leading molecules, with the vast majority manufactured at the two Italian sites. Labochim is located near Milan, while Mediolast has their plant near Lodi. Key technologies include industrial diafiltration by means of selective membranes, alkylations, halogenations, high vacuum distillations, and phase tranfer reactions.The Labochim Milan site includes both the mutlipurpose facility as well as a cGMP pilot suite housing three 100 liter reactors. Through a recent exclusive arrangement, Infa is offering peptides from a leading peptide manufacturer from India, Hemmo Pharma.